These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15722814)

  • 1. Analgesic effects of topical methadone: a report of four cases.
    Gallagher RE; Arndt DR; Hunt KL
    Clin J Pain; 2005; 21(2):190-2. PubMed ID: 15722814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone for cancer pain: a case report.
    Nixon AJ
    Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
    [No Abstract]   [Full Text] [Related]  

  • 3. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in Palliative Care Patients: Are the Sigma-1 Receptors Involved?
    Cobos EJ; Baeyens JM
    J Palliat Med; 2015 Aug; 18(8):660. PubMed ID: 26087240
    [No Abstract]   [Full Text] [Related]  

  • 5. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
    Mercadante S
    Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
    Fisher K; Stiles C; Hagen NA
    J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from parenteral to oral methadone.
    González-Barboteo J; Porta-Sales J; Sánchez D; Tuca A; Gómez-Batiste X
    J Pain Palliat Care Pharmacother; 2008; 22(3):200-5. PubMed ID: 19042849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report.
    Salpeter SR; Buckley JS; Buckley NS; Bruera E
    J Palliat Med; 2015 Feb; 18(2):114-9. PubMed ID: 25494475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of methadone to another opioid in the management of moderate to severe cancer pain: a case series.
    Wallace E; Ridley J; Bryson J; Mak E; Zimmermann C
    J Palliat Med; 2013 Mar; 16(3):305-9. PubMed ID: 23391350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
    Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
    J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine infusor pump switch to oral methadone.
    Santos Suárez J; Del Valle Arnáez G
    BMJ Support Palliat Care; 2020 Mar; 10(1):1-3. PubMed ID: 30944123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations.
    Manfredi PL; Borsook D; Chandler SW; Payne R
    Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.
    Reddy S; Fisch M; Bruera E
    J Pain Symptom Manage; 2004 Oct; 28(4):301-3. PubMed ID: 15471646
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomised controlled trial to test the analgesic efficacy of topical morphine on minor superficial and partial thickness burns in accident and emergency departments.
    Welling A
    Emerg Med J; 2007 Jun; 24(6):408-12. PubMed ID: 17513537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
    LeBaron V; Brody J; Lee EM; Hardin C; Snyder L
    J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone for pain: No. 75.
    Gazelle G; Fine PG
    J Palliat Med; 2004 Apr; 7(2):303-4. PubMed ID: 15130209
    [No Abstract]   [Full Text] [Related]  

  • 19. Methadone for Pain Relief.
    Johnson J; Sheth S
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):146-7. PubMed ID: 27159280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.